
A 32-year-old primigravid woman developed acquired factor VIII inhibitor after delivery. She presented with postpartum hemorrhage and large hematoma in episiotomy site. Laboratory examinations showed markedly prolonged activated partial thromboplastin time, low levels of factor VIII (8%), and factor VIII inhibitor (2 Bethesda units). The bleeding was controlled successfully using combined treatment with factor VIII, intravenous immunoglobulin, steroids, and recombinant factor VIIa. Six months after delivery, factor VIII inhibitor was not present and factor VIII concentration increased to normal range. Acquired hemophilia is a life-threatening disorder. Precise screening of coagulation factors is essential for diagnosis of persisting postpartum hemorrhage.
Adult, Postpartum Hemorrhage, Pregnancy Complications, Hematologic, Infant, Newborn, Factor VIIa, Factor VII, Hemophilia A, Recombinant Proteins, Pregnancy, Injections, Intravenous, Humans, Female, Partial Thromboplastin Time, Follow-Up Studies
Adult, Postpartum Hemorrhage, Pregnancy Complications, Hematologic, Infant, Newborn, Factor VIIa, Factor VII, Hemophilia A, Recombinant Proteins, Pregnancy, Injections, Intravenous, Humans, Female, Partial Thromboplastin Time, Follow-Up Studies
| citations The total number of citations received by all articles of the researcher of interest. | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
